SEARCH

SEARCH BY CITATION

References

  • 1
    Noseworthy JH. Progress in determining the causes and treatment of multiple sclerosis. Nature 1999; 399 (Suppl. 24):A40A46.
  • 2
    Brosnan C & Raine C. Mechanisms of immune injury in multiple sclerosis. Brain Pathol 1996; 6: 24357.
  • 3
    Sakai K, Zamvil GS & Mitchell JD et al. Characterisation of a major T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J Neuroimmunol 1988; 19: 2132.
  • 4
    Amor S, Baker D & Groome N et al. Identification of major encephalitogenic epitope (residues 56–70) of proteolipid protein for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and non-obese diabetic mice. J Immunol 1993; 150: 566672.
  • 5
    Amor S, Groome N & Linnington C et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1994; 153: 434956.
  • 6
    Dworkin RH, Bates D & Millar JHD et al. Linoleic acid and multiple sclerosis: a reanalysis of three double blind trials. Neurology 1984; 34: 14415.
  • 7
    Meade CJ, Mertin J & Sheena J et al. Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea-pig. J Neuro Sci 1978; 35: 291308.
  • 8
    Hughes D, Keith AB & Mertin J et al. Linoleic acid therapy in severe experimental allergic encephalomyelitis in the guinea pig. Clin Exp Immunol 1980; 41: 52331.
  • 9
    Phylactos AC, Harbige LS & Crawford MA. Essential fatty acids alter the activity of manganese superoxide dismutase in rat heart. Lipids 1994; 29: 1115.
  • 10
    Harbige LS, Yeatman N & Amor S et al. Prevention of experimental autoimmune encephalomyelitis in Lewis rats by a novel fungal source of γ-linolenic acid. Br J Nutr 1995; 74: 70115.
  • 11
    Fan Y & Chapkin RS. Mouse peritoneal macrophage prostaglandin E1 synthesis is altered by dietary gamma-linolenic acid. J Nutr 1992; 122: 16006.
  • 12
    Phipps RP, Stein SH & Roper RL. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991; 12: 34952.
  • 13
    Goetzl EJ, An S & Smith WL. Specificity of expression and effects of eicosanoid mediators in normal physiology and human disease. FASEB J 1995; 9: 10518.
  • 14
    Harbige LS, Layward L & Morris M et al. Cytokine secretion by human T cell clones is differentially regulated by eicosanoids. Trans Biochem Soc 1997; 25: 347S.
  • 15
    Watanabe S, Yssel H & Harada Y et al. Effects of prostaglandin E2 on Th0-type human T cell clones: modulation of functions of nuclear proteins involved in cytokine production. Int Immunol 1994; 6: 52332.
  • 16
    Fisher BAC & Harbige LS. Effect of omega-6 lipid-rich borage oil feeding on immune function in healthy volunteers. Trans Biochem Soc 1997; 25: 343S.
  • 17
    Mertin J & Stackpoole A. Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by indomethacin. Prostaglandins Med 1978; 1: 28391.
  • 18
    Mertin J & Stackpoole A. The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors. Clin Exp Immunol 1979; 36: 44955.
  • 19
    Folch J, Lees M & Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animals tissues. J Biol Chem 1957; 226: 497509.
  • 20
    Feinberg AP & Vogelstein B. Addendum: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1984; 137: 2667.
  • 21
    Martin P, Dickson MC & Millan FA et al. Rapid induction and clearance of TGFβ1 is an early response to wounding in the mouse embryo. Dev Genet 1993; 14: 22538.
  • 22
    Sellmayer A, Weber PC & Bonventre JV. Modulation of cell growth and expression of early response genes by endogenous arachidonic acid metabolites. In: SinclairA, GibsonR, eds. Essential fatty acids and eicosanoids. Third International Congress. Champaign, IL: American Oil Chemists Society, 1993: 4505.
  • 23
    Goldyne ME & Stobo JD. Immunoregulatory role of prostaglandins and related lipids. CRC Crit Rev Immunol 1981; 2: 189223.
  • 24
    Harbige LS, Layward L & Amor S et al. Immunomodulatory effects of linoleic and gamma-linolenic acid-rich oil in experimental autoimmune encephalomyelitis. Immunology 1994; 83 (Suppl. 1):55.
  • 25
    Mertin J & Huges D. Specific inhibitory action of polyunsaturated fatty acids on lymphocyte transformation induced by PHA and PPD. Inter Archs Allergy Appl Immunol 1975; 48: 20310.
  • 26
    Calder PC. Fatty acids, dietary lipids and lymphocyte functions. Trans Biochem Soc 1995; 23: 3029.
  • 27
    Calder PC. Dietary fatty acids and lymphocyte functions. Proc Nutr Soc 1998; 57: 487502.
  • 28
    Santoli D & Zurier RB. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism. J Immunol 1989; 143: 13039.
  • 29
    Calder PC, Bevans SJ & Newsholme EA. The inhibition of T lymphocyte proliferation by fatty acids is via an eicosanoid independent mechanism. Immunology 1992; 75: 10815.
  • 30
    Harbige LS. Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease. Proc Nutr Soc 1998; 57: 55562.
  • 31
    Racke MK, Cannella B & Albert P et al. Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis. Int Immunol 1992; 4: 61520.
  • 32
    Racke MK, Dhib-Jalbut S & Cannella B et al. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J Immunol 1991; 37: 7584.
  • 33
    Santambrogio L, Hochwald GM & Saxena B et al. Studies on the mechanisms by which transforming growth factor-β protects against allergic encephalomyelitis. J Immunol 1993; 151: 111627.
  • 34
    Schull MM, Ormsby I & Kier AB et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992; 395: 6939.
  • 35
    Gorelik L & Flavell RA. Abrogation of TGFβ signalling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000; 12: 17181.
  • 36
    Ovadia H & Paterson PY. Effect of indomethecin treatment upon actively induced and transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol 1982; 49: 38692.
  • 37
    Mertin J, Stackpoole A & Shumay SJ. Nutrition and immunity: the immunoregulatory effect of n-6 essential fatty acids is mediated through prostaglandin E. Int Archs Allergy Appl Immunol 1985; 77: 3905.
  • 38
    Karpus WJ & Swanborg RH. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-β. J Immunol 1991; 146: 11638.
  • 39
    Issazadeh S, Mustafa M & Ljungdahl A et al. Interferon gamma, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res 1995; 40: 57990.
  • 40
    Khoury SJ, Hancock WW & Weiner HL. Oral tolerance to the myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176: 135564.
  • 41
    Suzumura A, Sawada M & Yamamoto H et al. Transforming growth factor-β suppresses activation and proliferation of microglia in vitro. J Immunol 1993; 151: 21508.
  • 42
    Liblau RS, Singer SM & McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16: 3438.
  • 43
    Fernandes G, Bysani C & Venkatraman JT et al. Increased TGFβ and decreased oncogene expression by ω-3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice. J Immunol 1994; 152: 597987.
  • 44
    Vidard L, Colarusso LJ & Benacerraf B. Specific T-cell tolerance may reflect selective activation of lymphokine synthesis. Proc Natl Acad Sci USA 1995; 92: 225962.
  • 45
    Pond CM. Interactions between adipose tissue and the immune system. Proc Nutr Soc 1996; 55: 11126.
  • 46
    Clausen J & Moller J. Allergic encephalomyelitis induced by brain antigen after deficiency in polyunsaturated fatty acids during myelination. Acta Neurol Scand 1967; 43: 37588.
  • 47
    Selivonchick DP & Johnston PV. Fat deficiency in rats during development of the central nervous system and susceptibility to experimental allergic encephalomyelitis. J Nutr 1975; 105: 288300.
  • 48
    Gul S, Smith AD & Thompson RHS et al. Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis. J Neurol Neurosurg Psychiat 1970; 33: 50610.
  • 49
    Homa ST, Belin J & Smith AD et al. Levels of linoleate and arachidonate in red blood cells of healthy individuals and patients with multiple sclerosis. J Neurol Neurosurg Psychiat 1980; 43: 10610.
  • 50
    Fisher M, Johnson MH & Natale AM et al. Linoleic acid levels in white blood cells, platelets and serum of multiple sclerosis patients. Acta Neurol Scand 1987; 76: 2415.
  • 51
    Navarro X & Segura R. Red blood cell fatty acids in multiple sclerosis. Acta Neurol Scand 1989; 79: 3237.
  • 52
    Beck J, Rondot P & Jullien P et al. TGF-β-like activity produced during regression of exacerbations in multiple sclerosis. Acta Neurol Scand 1991; 84: 4525.
  • 53
    Rieckmann P, Albrecht M & Kitze B et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 1994; 44: 15236.
  • 54
    Mokhtarian F, Shi Y & Shirazian D et al. Defective production of anti-inflammatory cytokine, TGF-β by T cell lines of patients with active multiple sclerosis. J Immunol 1994; 152: 600310.
  • 55
    Bertolotto A, Capobianco M & Malucchi S et al. Transforming growth factor β1 (TGF-β1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients. Neuroscience Lett 1999; 263: 2124.